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Childhood obesity is commonly associated with early signs of endothelial dysfunction, characterized by
impairment of insulin signaling and vascular Nitric Oxide (NO) availability. However, the underlying
mechanisms remain to be established. Hence, we tested the hypothesis that endothelial insulin-
stimulated NO production and availability was impaired and related to Endoplasmic Reticulum (ER) in
human umbilical vein endothelial cells (HUVECs) cultured with plasma obtained from pre-pubertal
obese (OB) children.
OB children (N ¼ 28, age: 8.8 ± 2.2; BMI z-score: 2.15 ± 0.39) showed impaired fasting glucose, insulin
and HOMA-IR than normal weight children (CTRL; N ¼ 28, age: 8.8 ± 1.7; BMI z-score: 0.17 ± 0.96). The
in vitro experiments showed that OB-plasma significantly impaired endothelial insulin-stimulated NO
production and bioavailability compared to CTRL-plasma. In parallel, in HUVECs OB-plasma increased
GRP78 and activated PERK, eIF2a, IkBa and ATF6 (all ER stress markers). Moreover, OB-plasma increased
NF-kB activation and its nuclear translocation. Notably, all these effects proved to be significantly
restored by using PBA and TUDCA, known ER stress inhibitors.
Our study demonstrate for the first time that plasma from obese children is able to induce in vitro
endothelial insulin resistance, which is characterized by reduced insulin-stimulated NO production and
bioavailability, endothelial ER stress and increased NF-kB activation.
© 2017 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Childhood obesity has reached epidemic proportions world-
wide, and has become amajor public health issue (Deckelbaum and
Williams, 2001). There is plenty of evidence that, in conjunction
with the growing epidemic of childhood obesity, cardiovascular
(CV) disease is becoming more prevalent (Cote et al., 2013). Obese
children are predisposed to the development of subclinical CV al-
terations early in life and to an increased CV morbidity anddicine Research Center (CeSI-
scara, “Gabriele d'Annunzio”
hieti, Italy.
Ireland Ltd. This is an open accessmortality in adulthood (Cote et al., 2013). Many metabolic and in-
flammatory factors are implicated in the pathogenesis of vascular
changes in obese children (Gidding and Daniels, 2016). In partic-
ular, insulin resistance (IR) represents a key link between childhood
obesity and the associated CV risk, being one of the first mecha-
nisms involved in the development of endothelial dysfunction
(Chiarelli and Marcovecchio, 2008). IR contributes to high blood
pressure, dyslipidemia, liver steatosis and increased carotid intima-
media thickness already in obese pre-pubertal children (D'Adamo
et al., 2008; de Giorgis et al., 2014; Giannini et al., 2008;
Marcovecchio et al., 2006). The presence of vascular IR can induce
an imbalance between pro- and anti-atherogenic endothelial in-
sulin signaling pathways. Such imbalance impairs endothelial Ni-
tric Oxide (NO) Synthase (eNOS) activation and NO release andarticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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It is known that NO, constitutively generated by endothelial cells,
plays an important role in themaintenance of vascular homeostasis
and in the pro-inflammatory response characterizing the early
stages of atherosclerosis (Fleming, 2010). Thus, a reduction in NO
bioavailability, which occurs under IR conditions (Muniyappa and
Sowers, 2013), promotes inflammation. A crucial step in this pro-
cess is the activation of nuclear factor kappa-light-chain-enhancer
of activated B cells (NF-kB)-pathway which, in turn, contribute to
endothelial dysfunction in the early stage of atherosclerosis, by
increasing the expression of adhesion molecules such as vascular
and intercellular cell adhesion molecules (VCAM and ICAM) (Di
Tomo et al., 2012).
Recently, Endoplasmic Reticulum (ER) stress has been linked to
vascular dysfunction (Cimellaro et al., 2016; Galan et al., 2014;
Lenna et al., 2014; Sozen et al., 2015) in the context of obesity
and IR (Leiria et al., 2013; Ozcan et al., 2004; Salvado et al., 2015;
Zhang et al., 2013; Zhou et al., 2012). One of the key roles of the
ER is to ensure proper synthesis, folding and transport of proteins
(Mollereau et al., 2014; Walter and Ron, 2011). When the ER be-
comes stressed due to the accumulation of newly synthesized
unfolded/misfolded proteins, unfolded protein response (UPR) is
activated. UPR is mediated by ER transmembrane receptor proteins
which are inositol-requiring kinase 1 (IRE1), double-stranded RNA-
activated protein kinase-like endoplasmic reticulum kinase (PERK)
and activating transcription factor 6 (ATF6) (Walter and Ron, 2011).
As a starting signal for UPR, misfolded proteins induce release of
glucose-regulated protein 78 (GRP78, also called BiP) from these
transmembrane stress sensors and therefore enhance their acti-
vation. Once activated: (i) IRE1 receptor, by its endoribonuclease
activity, cleaves a 26 base-pair segment from the mRNA of the X-
box binding protein-1 (XBP1), creating an alternative message that
is translated into the active (or spliced) form of the transcription
factor (XBP1s); (ii) by phosphorylation, PERK activates eukaryotic
translation initiation factor 2 alpha (eIF2a); (iii) the third branch of
UPR requires translocation of ATF6 to the Golgi apparatus where it
is cleaved to produce an active transcription factor (Hotamisligil,
2010).
The severity and duration of the stress response are crucial in
determining the cell fate between survival and death, mild and/or
acute ER stress generally resulting in adaptation and severe and/or
chronic ER stress resulting in cellular dysfunction and/or cell
apoptosis (Mollereau et al., 2014).
Recent findings have shown that ER stress and UPR pathways
link to major inflammatory and stress signaling networks,
including activation of NF-kB- inhibitor a (IkBa)- pathways (IKK), as
well as production of ROS (Gotoh and Mori, 2006; Hotamisligil,
2010; Nakajima and Kitamura, 2013; Tam et al., 2012). Interest-
ingly, UPR has also been related to obesity-associated IR in pe-
ripheral organs such as the liver (Ozcan et al., 2004). Based on such
evidence, we hypothesized that in pre-pubertal obese children ER
stress might play a crucial role in modulating NO endothelial
bioavailability through regulation of insulin signaling.
Up to now, only a few studies have investigated NO bioavail-
ability in obese pre-pubertal children and adolescents (Codoner-
Franch et al., 2011; Gruber et al., 2008) suggesting impaired NO
bioavailability in obese youth, but the cellular mechanisms un-
derlying NO regulation and the potential involvement of ER stress
have not been investigated yet.
In the present study, we demonstrate that in human umbilical
vein endothelial cells (HUVECs) plasma from obese children is able
to induce endothelial ER stress and this is associated with increased
inflammation and reduced insulin-stimulated NO production and
bioavailability. Furthermore, we found that inhibition of ER stress
significantly improves vascular insulin resistance in vitro,suggesting that new mechanisms are potentially involved in
childhood obesity-related vascular dysfunction.
2. Materials and methods
2.1. Study population
Plasma was obtained from 28 obese and 28 normal-weight
prepubertal children. Obese children were recruited from patients
attending the Pediatric Endocrinology Clinic of the Department of
Pediatrics, University of Chieti, Italy. The study protocol was
approved by the Ethics Committee of the University of Chieti, and,
in adherence with the Declaration of Helsinki, written informed
consent was obtained from all subjects taking part in the study.
All subjects were obese (BMI>95th percentile for age and sex),
but otherwise healthy. None had other chronic diseases (diabetes,
endocrine disorders, hereditary diseases, or systemic inflamma-
tion) or were taking any medication. The control group was
recruited from children attending the Pediatric outpatient clinics
for a general check 1e2 weeks after a previous admission to our
Pediatric ward for minor diseases (mainly gastroenteritis and
trauma). At the time of assessment, these children were in good
general health with complete resolution of the original disease. The
inclusion criteria of the control group were: normal weight (BMI
between 5 and 85th for age and sex), being otherwise in good
health and not having any chronic disease. None of the patients was
taking anymedication and none had a history of smoking or alcohol
consumption.
All children underwent a complete physical examination,
including anthropometric measurements (height, weight, BMI).
Fasting blood samples were collected to measure glucose and in-
sulin levels and for the in vitro studies. The Homeostasis Model
Assessment of insulin resistance (HOMA-IR) was used as a surro-
gate index of insulin resistance and it was calculated as: [fasting
insulin (mU/l)  fasting glucose (mmol/l)/22.5] (Matthews et al.,
1985).
2.2. Anthropometric measurements
Body weight was determined to the nearest 0.1 kg, and height
was measured by Harpenden stadiometer to the nearest 0.1 cm.
BMI and WC were used as indexes of adiposity. BMI was calculated
as the weight in kilograms divided by the square of the height in
meters and was converted into standard deviation scores (SDS)
using published reference values for age and sex for the Italian
population (Cacciari et al., 2006).
2.3. Biochemical analysis
Serum glucose levels were determined using the glucose oxi-
dase method, and serum insulin levels were measured by the two-
site immunoenzymetric assay (AIA-PACK IRI; Tosoh, Tokyo, Japan).
2.4. Plasma collection
At the time of blood collection all subjects were fasting and free
of common infectious diseases. Blood was drawn by venipuncture
into evacuated tubes containing ethylenediaminetetraacetic acid
(EDTA). In order to obtain the plasmatic fraction, the whole blood
was centrifuged at 1578 g for 10 min room temperature, the
separated plasmawas stored at 80 C until experimental analysis.
2.5. Antibodies and materials
M199 endothelial growth medium, DMEM, glutamine,
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sigargin (Thaps), N-nitro l-arginine methyl ester (L-NAME, LN), 1 H-
oxadiazole-[4,3-alpha]-quinoxalin-1-one (ODQ), Tauroursodeox-
ycholic acid (TUDCA), Tris/HCl, EDTA and Dowex AGWX8-200 were
from Sigma Chemicals (St.Louis, MO, USA). Fetal Bovine Serum
(FBS) was purchased from GIBCO-Life-Technologies (Monza, Italy)
and tissue-culture disposables were from Eppendorf (Hamburg,
Germany). Anti-eNOS and anti-phosphorylated-eNOS (Serine 1177)
antibodies were from BD Biosciences (Becton Dickinson, Milan,
Italy) while antibodies, anti-protein kinase B (Akt), anti-
phosphorylated-Akt (Serine 473), anti-glucose-regulated protein-
78 kDa (GRP78), protein kinase RNA-like endoplasmic reticulum
kinase (PERK), phosphorylated-PERK (p-PERK), eukaryotic trans-
lation initiation factor-2alpha (eIF2a), phosphorylated-eIF2a (p-
eIF2a), X-box binding protein-1 spliced (XBP1s), nuclear factor of
kappa light polypeptide gene enhancer in B-cells inhibitor-alpha
(IkBa), phosphorylated-kBa (p-IkBa) and nuclear factor kappa-
light-chain-enhancer of activated B cells (NF-kB) were from Cell
Signaling Technology (Beverly, MA, USA). Tunicamycin (Tunica),
activating transcription factor-6 (ATF6 cleaved and not cleaved),
inositol-requiring enzyme-1 (IRE1) and phosphorylated-IRE1 (p-
IRE1) antibodies were from Abcam (Cambridge, UK). Anti-b-actin
mousemonoclonal antibody was from Sigma Aldrich (St. Louis, MO,
USA). For flow cytometry, FITC-labeled secondary antibodies were
from thermo-fisher (Milan, Italy) and DRAQ-5 was from Biostatus
(UK). 4-Phenylbutyric acid (PBA) was from Calbiochem (Italy). L-
(3H)-arginine was purchased from PerkinElmer Italia S. p.a. (Milan,
Italy).
2.6. Cell cultures
Umbilical cords were obtained from randomly selected healthy
Caucasian mothers delivering at the Hospital of Chieti and Pescara.
All procedures were in agreement with the ethical standards of the
Institutional Committee on Human Experimentation and with the
Declaration of Helsinki Principles. After approval of the protocol by
the Institutional Review Board, signed informed consent was ob-
tained from each participating subject. Primary HUVECs were ob-
tained as described previously and used between the 3rd and 5th
passages in vitro (Di Fulvio et al., 2014). In this study, fifteen
different HUVEC batches were employed and each experiment was
performed on cells coming at least from three different batches.
2.7. Experimental protocols
In order to assess the NOS activity and cGMP levels HUVECs
were serum starved for 16 h and then grown for 24 h with 10%
plasma obtained from OB- (plasma OB, N ¼ 13) or CTRL-children
(plasma CTRL, N ¼ 13) or with 10% FBS (as Basal control) in the
presence or absence of insulin (Ins,100 nM). In some experiments
2 mM of ionomycin (Ion, positive control), 1 mM of L-NAME (LN,
selective inhibitor of NO synthase activity) and 10 mM ODQ (heme-
site inhibitor of soluble guanylyl cyclase competitive with NO) were
also employed. Moreover, in order to evaluate the possible
involvement of ER stress, in some other experiments 5 mM PBA or
500 mM TUDCA (ER stress inhibitors) was pre-incubated for 1 h and
left for the last 24 h.
In order to investigate the effect of plasma OB on Akt and eNOS
phosphorylation levels and the possible involvement of ER stress,
quiescent HUVECs (16 h starvation) were pretreated or not for 1 h
with PBA (10 mM) and TUDCA (1 mM, ER stress inhibitor), then
incubated for 3 h with Thaps (1 mM) or Tunica (1 mM, both ER stress
inducers) in baseline condition, or with 10% FBS (as Basal control)
and a 10% of three different plasma pool (each pool with six OB- or
CTRL-plasmas) while insulin (100 mM) was added for 15 min.To thoroughly evaluate ER stress marker induction (Oslowski
and Urano, 2011) (GRP78, PERK, eIF2a, ATF6, IRE1, XBP1s and
IkBa) and NF-kB activation and nuclear translocation, HUVECs were
treated as described above, following a temporary (3hrs, also called
early induction, see eNOS phosphorylation experimental protocol
above) or chronic (24hrs, also called late induction, see NOS activity
and cGMP levels experimental protocol above) incubationwith OB-
and CTRL-plasmas or FBS (Basal Control).
It is important to specify that plasmawas used both individually
and in a pool of six plasmas. The pool of six OB- or CTRL-plasmas
was used because of the difficulty in obtaining an adequate
amount of blood from children.
2.8. NOS activity by conversion of L-[3H]-arginine into L-[3H]-
citrulline
Insulin-stimulated NOS activity was evaluated in HUVECs
cultured with 10% plasma obtained from OB- (N ¼ 13) or CTRL-
children (N ¼ 13) as described in the experimental protocol by
measuring the conversion of L-[3H]-arginine into L-[3H]-citrulline
as previously described (Di Pietro et al., 2006).
2.9. Intracellular cGMP determination
Since increased/decreased NO synthesis does not necessarily
translate into increased/decreased NO bioavailability, wemeasured
the intracellular cGMP levels, a good proxy for NO in the vascula-
ture which ought to reflect the bioavailable NO. Intracellular cGMP
levels were evaluated in HUVECs cultured with 10% plasma ob-
tained from OB- (N ¼ 13) or CTRL-children (N ¼ 13) as described in
the experimental protocol using a commercially available Enzyme
Immunoassay (EIA) kit (GE Healthcare, Little Chalfont, Buck-
inghamshire, UK) following the manufacturer's instructions.
2.10. Flow cytometry
ER stress and inflammatory pathways were determined in
HUVECs cultured with 10% plasma obtained from OB- (N ¼ 13) or
CTRL-children (N¼ 13) or with a pool of six OB- or CTRL-plasmas as
described in the experimental protocol by flow cytometry or im-
aging flow cytometry analysis performed as previously reported
(Lanuti et al., 2016). Briefly, samples were fixed and permeabilized
by using the IntraSure Kit (BD Biosciences), as suggested by the
manufacturer's instructions. Cells were, then stained by primary
antibodies against markers of vascular insulin signaling (mouse
anti-eNOS, mouse anti-phospho-Ser1177eNOS, rabbit anti-Akt and
anti-phospho-Ser473Akt), ER stress (rabbit anti-GRP78, rabbit anti-
PERK, rabbit anti-p-PERK, mouse anti-eIF2a, rabbit anti-p-eIF2a,
mouse anti-ATF6, rabbit anti-IRE1, rabbit anti-p-IRE1 and rabbit
anti-XBP1s) and vascular inflammatory markers (mouse anti-IkBa,
mouse anti-p-IkBa, rabbit anti-NF-kB). The incubation of primary
antibody was followed by incubation with the specific FITC-labeled
secondary antibody. For some experiments, the nucleus was
stained with Biostatus-DRAQ5.
For flow cytometry, cells were analyzed on a FACS Canto II flow
cytometer (BD Biosciences), using CellQuest™ software 3.2.1. f1
(BD) (Lanuti et al., 2006). Quality control included a regular check-
up with Cytometer Setup and Tracking (CS&T) beads (BD Bio-
sciences). Debris was excluded from the analysis by gating on
morphological parameters; 10,000 non-debris events in the
morphological gate were recorded for each sample. All antibodies
were titrated under assay conditions and optimal photomultiplier
(PMT) gains were established for each channel. Data were analyzed
using FlowJo™ v.8.8.6 software (TreeStar, Ashland, OR). The Mean
Fluorescence Intensity Ratio (MFI Ratio) was calculated dividing the
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For imaging flow cytometry sample acquisitions were per-
formed by ImageStream (Amnis, Seattle, WA, USA; one laser, six-
color configuration) (Bologna et al., 2014). To assess unspecific
fluorescence, samples were stained with the respective secondary
antibody alone. Analyses were performed by IDEAS software
(Amnis). Data were indicated as a percentage of the markers
mentioned above positive cells in live cells either permeabilized or
not.
2.11. Statistical analysis
All data were expressed as means ± SD or median [interquartile
range], unless otherwise stated. Not normally distributed variables
were log transformed before data analysis. Differences between the
two study groups in continuous variables were tested by unpaired
t-test. For in vitro studies, differences were assessed by the Student
t-test and by ANOVA test. P values < 0.05 were considered statis-
tically significant.
3. Results
3.1. Clinical and metabolic characteristics
Table 1 shows the general characteristics of the study popula-
tion which included 28 obese (OB) and 28 normal-weight (CTRL)
children. The two groups were comparable for age, whereas, as
expected, weight, BMI and BMI z-score were higher in obese than
control children. Fasting glucose, insulin and HOMA-IR were
significantly higher in obese than in control children.
3.2. Basal and stimulated NO production
We first assessed whether plasma from OB-children might
impair the NO production in insulin-stimulated HUVECs as
compared to cells incubated with plasma from CTRL-children. As
shown in Fig. 1, in cells treated for 24 h with 10% OB-plasma insulin
was unable to increase NO release which, on the contrary, signifi-
cantly increased in HUVECs treated with 10% CTRL-plasma. Pre-
incubation with L-NAME, a known NOS inhibitor, significantly
reduced insulin-stimulated NO production. In addition, to test the
hypothesis that ER stress might trigger endothelial IR, HUVECs
were pre-incubated with PBA (5 mM), a chemical chaperone that is
known to reduce ER stress in vitro and in vivo (Oslowski and Urano,
2011). Interestingly, PBA significantly restored insulin-mediated NO
production in endothelial cells cultured with OB-plasma and the
use of L-NAME significantly abolished this effect. In the same
experimental condition, HUVECs were stimulated by ionomycin, a
calcium ionophore that induces NO production mainly via mobili-
zation of intracellular Ca2þ. Differently from the result obtained
following insulin stimulation, NO release was significantlyTable 1
Clinical and biochemical characteristics of the study population.
Obese children Control children P value
N 28 28
Age (years) 8.8 ± 2.2 8.8 ± 1.7 0.94
Height (cm) 135.8 ± 11.4 126.0 ± 10.7 0.003
Weight (Kg) 50.9 ± 10.1 26.3 ± 9.3 <0.001
BMI (Kg/m2) 27.4 ± 2.9 17.4 ± 3.0 <0.001
BMI z-score 2.15 ± 0.39 0.17 ± 0.96 <0.001
Glycemia (mg/dl) 87.5 ± 8.9 79.4 ± 7.0 0.001
Insulin (mU/ml) 15.0 [11.4e22.1] 6.2 [5.2e7.3] <0.001
HOMA 3.3 [2.5e4.2] 1.2 [1.1e1.4] <0.001
Data are mean ± SD or median [25th-75th percentile].increased by ionomycin compared to the basal condition and pre-
treatment with L-NAME totally abolished this effect. This result
suggests that in HUVECs the role of OB-plasma in reducing insulin
stimulated NO production was specific. .
In order to assess the integrity of eNOS activation system,
HUVECs were cultured both under normal growth conditions (10%
FBS) and CTRL-plasma and then exposed to insulin or ionomycin. In
these conditions, insulin- and ionomycin-stimulated endothelial
NO production proved to be both increased while pretreatment
with L-NAME completely abolished these effects.
3.3. Basal and stimulated cGMP levels
We next investigated whether endothelial cells treatedwith OB-
or CTRL-plasma were able to generate insulin-stimulated bioactive
NO. For this purpose, we measured the formation of cGMP, a good
proxy for NO, because soluble guanylate cyclase is activated by
nanomolar concentrations of the gas (Bulotta et al., 2001; Di Tomo
et al., 2012).
As shown in Fig. 2, exposure to insulin resulted in a significant
increase in cGMP over controls in HUVECs treated for 24 h both
with 10% FBS and with CTRL-plasma, which were both inhibited by
the presence of L-NAME. On the contrary, insulin was unable to
increase cGMP levels when HUVECs were cultured for 24 h with
10% OB-plasma. Notably, pre-incubation of HUVECs with PBA
significantly reversed this phenomenon, indicating that this may be
associated with ER stress and the use of L-NAME significantly
abolished this effect. HUVECs under normal growth conditions (10%
FBS) or incubated with 10% CTRL- or OB-plasma were also stimu-
lated with ionomycin which significantly increased cGMP levels in
all conditions. In the same experimental settings, pre-incubation
with L-NAME significantly abolished these effects. Furthermore,
in order to discriminate between cGMP-dependent and cGMP-
independent NO effects, the ODQ (heme-site inhibitor of soluble
guanylyl cyclase competitive with NO) was used. This GC-inhibitor
significantly abolished the insulin and ionomycin effects, suggest-
ing a NO-activation of guanylyl cyclase.
3.4. Effect of ER stress on insulin-stimulated Akt and eNOS
phosphorylation
We then evaluated whether OB-plasma might impair insulin-
stimulated Akt and eNOS activation by phosphorylation. First, we
evaluated the phosphorylation levels in Serine 473 of Akt, which is
a known upstream regulator of eNOS in the insulin-signalling
cascade. Incubation of HUVECs with OB-plasma significantly
decreased the insulinestimulated Akt phosphorylation levels (2
folds vs Basal condition p < 0.05) while in normal growth condition
and in cells incubated with CTRL-plasma Akt phosphorylation
levels was increased (2.5 folds and 2.2 folds vs Basal condition
p < 0.05, respectively).
Then, we focused on eNOS activation, the pivotal enzyme in the
endothelial NO production. As shown in Fig. 3, exposure to insulin
significantly increased phospho-Ser1177eNOS levels over controls in
HUVECs treated for 3 h both with 10% FBS and with 10% CTRL-
plasmas (three different pool of six different CTRL-plasma). On
the contrary, insulinwas not able to increase eNOS phosphorylation
levels following incubation with 10% OB-plasma (three different
pool of six different OB-plasmas). Interestingly, this result was
reversed after pre-incubation of HUVECs with known ER stress
inhibitors (Oslowski and Urano, 2011) such as PBA or TUDCA,
proving the involvement of ER stress. By way of experimental
control, HUVECs under normal growth conditions (10% FBS) were
also stimulated for 3hrs with thapsigargin or tunicamycin, a known
inducers of ER stress (Oslowski and Urano, 2011). Notably,
Fig. 1. Basal and stimulated NO production. HUVECs serum starved were incubated for 24 h with plasma obtained from OB- (plasma OB, N ¼ 13) or CTRL-children (plasma CTRL,
N ¼ 13) or with 10% FBS (as Basal control). Insulin (Ins), Ionomycin (Ion), L-NAME (LN) and PBA were also employed. NOS activity was determined by the conversion of L-[3H]-
arginine into L-[3H]-citrulline and expressed as pmol/NO/min/mg prot tot. Data were expressed as means ± SD of at least six different experiments. *p < 0.02 vs Basal; #p < 0.02 vs
Ins; yp < 0.009 vs InsþPBA; zp < 0.004 vs Ion; xp < 0.005 vs IonþPBA; Fp < 0.02 vs Ins baseline and Ins plasma CTRL; Up < 0.02 vs Ins plasma OB.
Fig. 2. Basal and stimulated cGMP levels. HUVECs serum starved were incubated for 24 h with 10% OB- (N ¼ 10) or CTRL-plasma (N ¼ 10) or with 10% FBS (Basal control). Insulin
(Ins), Ionomycin (Ion), ODQ, L-NAME (LN) and PBA were also employed. The inset shows the effect of ODQ, LN and PBA by themselves or in association on unstimulated HUVECs.
Intracellular cGMP levels are expressed as mean of cGMP fmol/well ±SD of at least six different experiments. *p < 0.02 vs Basal; #p < 0.02 vs Ins; zp < 0.01 vs InsþPBA; **p < 0.02 vs
Ion; xp < 0.01 vs IonþPBA; Fp < 0.005 vs Ins baseline and Ins plasma CTRL; yp < 0.004 vs Ins plasma OB; no significant (n.s.).
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lation levels compared to basal condition while, as expected, pre-
incubation with either PBA or TUDCA restored the levels to base-
line. In addition, tunicamycin significantly inhibited insulin-
stimulated eNOS phosphorylation, indicating that induction of ER
stress might be relevant to inducing IR in vascular endothelial cells.
On the contrary, the stimulation with thapsigargin significantly
increased the phospho-Ser1177eNOS levels. This is not surprising
considering that, although the thapsigargin is considered an ERstress inducer, it is also known as an agonist of the calcium-
mediated activation of eNOS.
3.5. ER stress marker induction
Since we found a potential ER stress involvement in the
impaired endothelial insulin-stimulated NO bioavailability trig-
gered by OB-plasma, we next focused on evaluation of the main ER
stress markers. In particular, we first evaluated the effect of OB-
Fig. 3. Effect of ER stress on basal and insulin-stimulated eNOS phosphorylation levels. HUVECs serum starved were pretreated or not with PBA or TUDCA, following 3 h stimulation
with: Thapsigargin (Thaps), Tunicamycin (Tunica), 10% FBS (Basal control) and 10% pool of six OB- or CTRL-plasmas. In some experiments insulin (Ins) was employed. Data were
expressed as phospho-Ser1177eNOS on total eNOS fold increase ± SD (at least three different experiments) of Mean Fluorescence Intensity Ratio (M.F.I Ratio) versus Basal condition.
M.F.I. Ratio was calculated dividing the M.F.I. of positive events by the M.F.I. of negative events. *p < 0.001 vs Basal; **p < 0.002 vs Basal; #p < 0.007 vs Tunica; yp < 0.001 vs Ins;
xp < 0.002 vs InsþTunica; zp < 0.001 vs Ins Basal; Up < 0.001 vs Ins plasma CTRL; Fp < 0.001 vs Ins plasma OB.
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membrane receptor proteins (PERK, IRE1 and ATF6) and their up-
stream regulator GRP78.
Incubation of HUVECs for 3 h (Fig. 4AeD) with 10% OB-plasma
(pool of six different OB-plasmas) significantly increased GRP78,
PERK phosphorylation, cleaved ATF6 levels and ATF6 nuclear
translocation (Fig. 5) as compared to incubation with 10% CTRL-
plasma (pool of six different CTRL-plasmas) or to basal condition
(10% FBS), while IRE1 proved not to be activated. The same results
were achieved after 24 h (Fig. 4EeH) incubation of HUVECs withFig. 4. Early and late induction of ER stress markers. (A-D) HUVECs serum starved were pret
10% FBS (Basal control) and 10% pool of six OB- or CTRL-plasmas. (E-H) HUVECs serum starve
(N ¼ 10) or CTRL-plasma (N ¼ 10), Thapsigargin (Thaps) or with 10% FBS (Basal control). (A
experiments) of Mean Fluorescence Intensity Ratio (M.F.I Ratio) versus Basal condition. M.
events. (A) GRP78 levels (*p < 0.02 vs Basal and vs Basal Thaps; #p < 0.001 vs Basal; yp < 0.002
as ratio of p-PERK on total PERK levels (*p < 0.008 vs Basal and vs Basal Thaps; #p < 0.003 vs
(*p < 0.02 vs Basal and vs Basal Thaps; #p < 0.001 vs Basal; yp < 0.002 vs Basal plasma CTRL; **
total IRE1 levels (*p < 0.002 vs Basal; **p < 0.02 vs Basal Thaps); (E) GRP78 levels (*p < 0.00
**p < 0.02 vs Basal plasma OB); (F) PERK and p-PERK, data expressed as ratio of p-PERK on tot
vs Basal plasma CTRL; **p < 0.002 vs Basal plasma OB); (G) ATF6 levels (*p < 0.009 vs Basal an
Basal plasma OB); (H) IRE1 and p-IRE1, data expressed as ratio of p-IRE1 on total IRE1 leve10% OB- or CTRL-plasma and 10% FBS. Meanwhile, in the same
experimental conditions, neither CTRL-plasma nor FBS (basal
condition) affected the expression of ER stress markers (Fig. 4AeH).
As a positive control, endothelial cells grown under normal con-
ditions (10% FBS) were also treated with thapsigargin for 3 h (1 mM,
Fig. 4AeD) or 24 h (20 nM, Fig. 4EeH). As expected, all the above-
mentioned ER stress markers proved significantly increased.
After measuring the activation of the three master regulators of
UPR, we focused on the potential activation of some downstream
effectors such as eIF2a, IkBa and XBP1s.reated or not with PBA or TUDCA, following 3 h incubation with: Thapsigargin (Thaps),
d were pretreated or not with PBA or TUDCA, following 24 h incubation with: 10% OB-
-H) All ER stress markers were expressed as fold increase ± SD (at least three different
F.I. Ratio was calculated dividing the M.F.I. of positive events by the M.F.I. of negative
vs plasma CTRL; **p < 0.002 vs Basal plasma OB); (B) PERK and p-PERK, data expressed
Basal; yp < 0.003 vs Basal plasma CTRL; **p < 0.003 vs Basal plasma OB); (C) ATF6 levels
p < 0.002 vs Basal plasma OB); (D) IRE1 and p-IRE1, data expressed as ratio of p-IRE1 on
9 vs Basal and vs Basal Thaps; #p < 0.0003 vs Basal; yp < 0.003 vs Basal plasma CTRL;
al PERK levels (*p < 0.004 vs Basal and vs Basal Thaps; #p < 0.0004 vs Basal; yp < 0.0005
d vs Basal Thaps; #p < 0.0003 vs Basal; yp < 0.0007 vs Basal plasma CTRL; **p < 0.003 vs
ls (*p < 0.0001 vs Basal; **p < 0.0006 vs Basal Thaps).
Fig. 5. ATF6 nuclear translocation. HUVECs serum starved were pretreated or not with PBA or TUDCA, following 3 h incubation with: Thapsigargin (Thaps), 10% FBS (Basal control)
and 10% pool of six OB- or CTRL-plasmas. (A) ATF6 nuclear translocation was indicated as mean of the percentage of ATF6 positive cells in live cells ± SD (*p < 0.003 vs Basal;
xp < 0.02 vs Basal Thaps; #p < 0.01 vs Basal; yp < 0.02 vs Basal plasma CTRL; **p < 0.009 vs Basal plasma OB); (B) Representative single cell images of ATF6 cytoplasm-nucleus
translocation in the absence (left panel) or in the presence of TUDCA (central panel) or PBA (right panel).
N. Di Pietro et al. / Molecular and Cellular Endocrinology 443 (2017) 52e6258HUVECs incubation with 10% OB-plasma for 24 h significantly
increased eIF2a and IkBa (Fig. 6A and B, respectively) phosphory-
lation levels, whereas, as expected, the spliced form of XBP1, XBP1s
(Fig. 6C), was not increased. In the same experimental condition ER
stress markers were unaffected by CTRL-plasma treatment, while
thapsigargin (20 nM) significantly increased eIF2a, IkBa and XBP1s.
All the ER stress markers triggered by thapsigargin were
reduced when HUVECs were pre-incubated with TUDCA and PBA
(Figs. 4e6).
3.6. NF-kB activation
We next demonstrated that incubation for 24 h with 10% plasma
from OB children triggered a significant increase in NF-kB activa-
tion in HUVECs as compared to plasma fromCTRL children (Fig. 7A).
Interestingly, OB-plasma also increased NF-kB nuclear trans-
location significantly more than did CTRL-plasma (Fig. 7B and C).Meanwhile, under the same experimental conditions, neither
CTRL-plasma nor 10% FBS affected the NF-kB expression and nu-
clear translocation (Fig. 7A and B-C, respectively).
The effect of incubation with thapsigargin (20 nM) for 24 h on
endothelial cells at baseline was also evaluated, demonstrating an
increase in both NF-kB activation and translocation (Fig. 7A and B-
C, respectively). These data may suggest that, in our cellular model,
apart from conventional inflammatory activation, ER stress also
takes part in NF-kB activation. Interestingly, the enhanced endo-
thelial NF-kB activation triggered by OB-plasma was significantly
reduced following pre-incubation with PBA and TUDCA (Fig. 7A).
These two ER stress inhibitors were also significantly effective in
inhibiting NF-kB nuclear translocation (Fig. 7B and C). We did not
observe any changes in the activation of NF-kB in HUVECs grown
under normal conditions (10% FBS) and incubated with ER stress
inhibitors (Fig. 7AeC).
Fig. 6. Downstream ER stress and inflammatory markers activation. HUVECs serum starved were pre-treated or not with PBA or TUDCA, following 24 h incubation with: 10% OB-
(N ¼ 10) or CTRL-plasma (N ¼ 10), Thapsigargin (Thaps) or with 10% FBS (Basal control). (A-C) All ER stress markers were expressed as fold increase ± SD (at least three different
experiments) of Mean Fluorescence Intensity Ratio (M.F.I Ratio) versus Basal condition. M.F.I. Ratio was calculated dividing the M.F.I. of positive events by the M.F.I. of negative
events. (A) eIF2a and p-eIF2a, data expressed as ratio of p-eIF2a on total eIF2a levels (*p < 0.0006 vs Basal and vs Basal Thaps; #p < 0.002 vs Basal; yp < 0.005 vs Basal plasma CTRL;
**p < 0.003 vs Basal plasma OB); (B) IkBa and p-IkBa, data expressed as ratio of p-IkBa on total IkBa levels (*p < 0.001 vs Basal and vs Basal Thaps; #p < 0.001 vs Basal; yp < 0.002 vs
Basal plasma CTRL; **p < 0.002 vs Basal plasma OB); (C) XBP1s levels (*p < 0.0001 vs Basal; **p < 0.002 vs Basal Thaps).
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Childhood obesity is commonly associated with early signs of
endothelial dysfunction, characterized by impairment of insulin
signaling, vascular NO availability and increased inflammation
(Chiarelli and Marcovecchio, 2008; Giannini et al., 2008;Fig. 7. NF-kB activation and nuclear translocation. HUVECs serum starved were pretreated
plasma (N ¼ 10), Thapsigargin (Thaps) or with 10% FBS (Basal control). (A) NF-kB levels w
Fluorescence Intensity Ratio (M.F.I Ratio) versus Basal condition. M.F.I. Ratio was calculated d
and vs Basal Thaps; #p < 0.002 vs Basal; yp < 0.001 vs Basal plasma CTRL; **p < 0.003 vs Basal
NF-kB positive cells in live cells ± SD (*p < 0.005 vs Basal, #p < 0.02 vs Basal plasma CTRL, yp <
NF-kB cytoplasm-nucleus translocation in the absence (left panel) or in the presence of TUMarcovecchio et al., 2006). Recently all these features have been
associated with ER stress (Flamment et al., 2012; Gotoh et al., 2011;
Lenna et al., 2014; Ozcan et al., 2004) and some recent studies have
also investigated the underlying mechanisms (Galan et al., 2014;
Gotoh and Mori, 2006; Leiria et al., 2013; Sozen et al., 2015; Tam
et al., 2012; Yang et al., 2015; Zeng et al., 2014; Zhang et al., 2013;or not with PBA or TUDCA, following 24 h incubation with: 10% OB- (N ¼ 10) or CTRL-
ere expressed as Fold increase ± SD (at least three different experiments) of Mean
ividing the M.F.I. of positive events by the M.F.I. of negative events (*p < 0.007 vs Basal
plasma OB); (B) NF-kB nuclear translocationwas indicated as mean of the percentage of
0.008 vs Basal, **p < 0.002 vs Basal plasma OB); (C) Representative single cell images of
DCA (central panel) or PBA (right panel).
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In particular, up to now there have been no findings regarding
the role of ER stress in the mechanism/s leading to vascular
dysfunction in the context of childhood obesity.
Hence, in the present study, for the first time, we showed that
plasma from pre-pubertal obese children impairs insulin-
stimulated NO production and bioavailability in endothelial cells.
Moreover, this is associated with increased ER stress induction,
given the increased levels of the main ER stress markers (GRP78,
PERK, ATF6, eIF2a and IkBa) and, in parallel, increased NF-kB acti-
vation, a known key component of the inflammatory response.
Interestingly, inhibition of ER stress, by chemical chaperones such
as PBA and TUDCA, ameliorates plasma OB-induced insulin resis-
tance and inflammation in HUVECs.
Hitherto only a few in vivo studies have investigated NO
bioavailability in obese pre-pubertal children and adolescents
(Codoner-Franch et al., 2011; Gruber et al., 2008). Gruber and col-
leagues (Gruber et al., 2008) suggested that juvenile (about 14 years
of age) obesity might contribute to atherogenesis via reduced NO
bioavailability. More recently, Codoner-Franch et al. (2011). re-
ported increased plasma levels of nitrite and nitrate, suggesting
increased nitrosative stress in severely obese children aged be-
tween 7 and 14 years. Although the above-mentioned studies agree
in indicating impaired NO bioavailability in obese youth, studies are
lacking on the mechanisms potentially involved in endothelial NO
bioavailability impairment relating to an IR condition in childhood.
Here, employing the innovative system of studying plasma from
obese children, we proved that such plasma induced insulin
resistance in cultured vascular endothelial cells. Thus, as compared
to plasma CTRL and basal condition, insulin stimulation failed to
induce an increase in NO production, bioavailability, eNOS and Akt
phosphorylation following incubation with plasma OB. It is inter-
esting to note that all these effects were reversed after HUVEC in-
cubation with ER stress inhibitors (PBA or TUDCA), suggesting that
the induction of ER stress is implicated in the vascular insulin
resistance triggered by plasma OB.
This result agrees with recent findings by Galan et al. (2014),
who showed that endothelial cells stimulated with tunicamycin
decreased the expression of active eNOS while this effect was
restored by using PBA or TUDCA.
Several lines of evidence suggest that ER stress is a potential
mechanism involved in both insulin resistance and endothelial
dysfunction (Flamment et al., 2012; Galan et al., 2014; Gotoh and
Mori, 2006, 2011; Leiria et al., 2013; Lenna et al., 2014; Ozcan
et al., 2004; Sozen et al., 2015; Zeng et al., 2014; Zhang et al.,
2013; Zhou et al., 2012). In particular, in line with our findings,
Zhou et al. (2012). have recently demonstrated that insulin-
stimulated eNOS activity, NO release and eNOS phosphorylation
were impaired in vascular endothelial cells and related to ER stress
following incubationwith serum from patients with chronic kidney
disease (CKD). Note that, as observed in our study, incubation with
ER stress inhibitors (PBA or TUDCA) annulled the inhibitory effect
triggered by CKD-serum.
In our study, once we had found that use of ER stress inhibitors
improved OB-plasma impaired vascular insulin sensitivity, we
looked more deeply at the effect of such plasma on unfolded pro-
tein response activation.
Here we noted that OB-plasma caused a significant increase in
ER stress upstream regulators GRP78, followed by activation of two
of the three main ER transmembrane receptor proteins PERK and
ATF6, while IRE1 and downstream XBP1 were not activated
following 3, 24 h (Fig. 4) and 1 h stimulation (data not shown).
In this regard, although it is known that the UPR is generally
driven by the activation of all three ER-localized transmembrane
signal transducers, recently several studies have reported possibledistinct involvement of the three UPR branches in metabolically
active tissues (Cimellaro et al., 2016; Kaplon et al., 2013; Puri et al.,
2008).
Furthermore, by evaluating eIF2a and IkBa activation, which are
downstream ER stress effectors of PERK, they both proved signifi-
cantly increased following OB-plasma incubation. In parallel, OB-
plasma triggered a significant increase in NF-kB activation and its
nuclear translocation in endothelial cells.
Recent findings have shown that ER stress and UPR pathways
connect with major inflammatory and stress signaling networks,
including activation of the IkBa pathway as well as production of
ROS and NO (Gotoh and Mori, 2006; Hotamisligil, 2010; Nakajima
and Kitamura, 2013; Tam et al., 2012).
In linewith these findings, in our cellular model PBA and TUDCA
significantly restores to basal condition both NF-kB activation and
nuclear translocation (Fig. 5). These data indicate that, conventional
activation apart, this transcription factor might be a consequence of
ER stress as also reported by other authors (Tam et al., 2012; Zeng
et al., 2014). In this regard, it has been shown that PERK mediates
the release of NF-kB from its inhibitor IkB and consequently, by its
nuclear-translocation, leads to expression of a variety of different
genes involved in inflammatory pathways (Hotamisligil, 2010). In
parallel, the ATF6 pathway has likewise been shown to directly
activate NF-kB (Hotamisligil, 2010).
More recently, Tam and colleagues (Tam et al., 2012) reported a
novel involvement of both PERK and IRE1 in the activation of NF-kB.
However, since IRE1 was not activated in our cellular model, we
suppose that NF-kB activation may be mainly linked to PERK-
mediated phosphorylation of eIF2a as previously reported by
other authors (Jiang et al., 2003). Furthermore, one might consider
that PERK could potentially represent an important crossroads
between inflammation and insulin resistance. In this connection, it
has recently been reported that inhibition of PERK improves
cellular insulin responsiveness at the level of FOXO activity (Zhang
et al., 2013).
In addition, although the molecular mechanism linking ER
stress and its effect on vascular insulin resistance remains unclear, a
potential role has been proposed for tribbles homolog 3 (TRIB3).
TRIB3 is a pseudo-kinase inhibitor of AKT, which is the direct up-
stream activator of eNOS (Prudente et al., 2012) and has been
shown to be relevant to insulin resistance (Bromati et al., 2011;
Leiria et al., 2013). Furthermore, TRIB3 has also been linked to ER
stress-induced insulin resistance in skeletal muscle from high-fat
diet-induced insulin resistant mice (Koh et al., 2013) as well as to
b-cell apoptosis via NF-kB pathway activation (Fang et al., 2014).
Thus, a possible role by TRIB3 in the impaired insulin response
triggered by plasma OB in our cellular model might be
hypothesized.
In addition, we have previously demonstrated that plasma from
obese children shows increased circulating inflammatory and
oxidative stress markers (sensitive C-reactive protein [hs-CRP] and
urinary isoprostanes [PGF-2a], respectively) (Giannini et al., 2008)
which are known to promote the early stage of atherogenesis. Thus,
one might hypothesize that these plasma biochemical alterations
may induce in vitro the impairment of several insulin stimulated
endothelial functions demonstrated in our cellular model.
Moreover, circulating microRNAs (miRNAs), a novel group of
non-coding small RNAs, have been found to be dysregulated in
metabolic diseases, such as obesity, type 2 diabetes and athero-
sclerosis (Vienberg et al., 2016). One notes that they have recently
been linked to the unfolded protein response pathways in relation
to various physiological processes. Since it has recently been
demonstrated that changes in circulating miRNAs are also associ-
ated with childhood obesity (Carolan et al., 2014; Prats-Puig et al.,
2013), one might also speculate that they contribute to the
Fig. 8. Effect of plasma from obese children on vascular endothelial cells. As summarized in this scheme plasma from severely obese children (Plasma OB) affect endothelial function
by acting on several intracellular signaling pathways. First, a reduced insulin sensitivity leads to decreased Akt and eNOS activation by phosphorylation and consequently reduction
of insulin-stimulated NO production and bioavailability, which, as well known, might contribute to endothelial dysfunction. Secondly, increased Endoplasmic Reticulum (ER) stress
activation leads to the induction of the Unfolded Protein Response (UPR) pathway. In particular GRP78 (ER stress upstream regulator), PERK and ATF6 (both ER stress trans-
membrane sensor proteins), eIF2a and ATF6 cleaved (both downstream ER stress markers) and IkBa (ER stress and Inflammatory marker) result all increased, while IRE1 results not
involved in this process. In parallel, the induction of these pathways lead to increase NF-kB activation, thus resulting in increased inflammatory response. In addition, it should be
emphasized that a mutual interaction probably exists between factors that cause ER stress and factors that are generated by ER stress. Thus, a vicious circle triggered by OB plasma
may contribute to endothelial dysfunction. Nitric Oxide (NO), endothelial Nitric Oxide Synthase (eNOS), protein kinase B (known as Akt), glucose-regulated protein 78 (GRP78, also
called BiP), inositol-requiring kinase 1 (IRE1), double-stranded RNA-activated protein kinase-like endoplasmic reticulum kinase (PERK), activating transcription factor 6 (ATF6),
eukaryotic translation initiation factor 2 alpha (eIF2a), nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IkBa), X-box binding protein-1 spilced
(XBP1s), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB).
N. Di Pietro et al. / Molecular and Cellular Endocrinology 443 (2017) 52e62 61mechanism causing ER stress induction in vascular cells. In this
regard, it has recently emerged that miRNAs are key regulators of
ER stress homeostasis and important players in UPR e dependent
signaling (Maurel and Chevet, 2013).
Taking these findings all together, it is clear that the molecular
mechanisms linking ER stress to insulin resistance in vascular
endothelial cells are numerous and require further study.
However, we believe that our study does add some key under-
standing of the deleterious effects that obesity may have on the
vasculature right from childhood, particularly in relation to the
induction of endothelial dysfunction.
In summary (Fig. 8), our study provides the first evidence that
plasma from pre-pubertal obese children reduces insulin-
stimulated NO production and bioavailability in endothelial cells,
which, in turn might contribute to endothelial dysfunction.
Furthermore, the present study highlights the involvement of ER
stress in this process, which in turn also increases the endothelial
inflammatory response. Although a deeper study of the underlying
mechanisms is necessary, our study could contribute to the
development of new preventive and therapeutic strategies aiming
to reduce the early onset of vascular complications even in
childhood.Funding sources
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